Merck's COVID-19 pill shows lower efficacy in updated data - Thomson Reuters Foundation

Merck's COVID-19 pill shows lower efficacy in updated data  Thomson Reuters FoundationMerck's Covid pill shows lower efficacy in updated data  CNBCFDA to Disclose Staff Review of Merck Covid-19 Pill  The Wall Street JournalMerck stock down 3% after its COVID-19 pill shows lower efficacy in updated data  Seeking AlphaEmory-developed COVID drug seeks FDA approval  Atlanta Journal ConstitutionView Full Coverage on Google News